Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
76
CCNE Quote, Financials, Valuation and Earnings
Last price:
$24.23
Seasonality move
:
1.54%
Day range:
$23.80 - $24.38
52-week range:
$19.32 - $29.29
Dividend yield:
2.97%
P/E ratio:
10.40x
P/S ratio:
2.25x
P/B ratio:
0.90x
Volume:
92.8K
Avg. volume:
84.2K
1-year change:
0.96%
Market cap:
$508.3M
Revenue:
$222M
EPS (TTM):
$2.33
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $159.6M | $189.4M | $219.6M | $218.1M | $222M | |
| Revenue Growth (YoY) | 14.61% | 18.63% | 15.97% | -0.68% | 1.77% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $53.1M | $65.8M | $77.1M | $78.1M | $80.8M | |
| Other Inc / (Exp) | $2.5M | $1.6M | -$498K | -$335K | $828K | |
| Operating Expenses | $40.5M | $65.8M | $77.1M | $78.1M | $80.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $40.1M | $70.8M | $78.2M | $71.8M | $67.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.3M | $13.1M | $15M | $13.8M | $12.8M | |
| Net Income to Company | $32.7M | $57.7M | $63.2M | $58M | $54.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $32.7M | $57.7M | $63.2M | $58M | $54.6M | |
| Basic EPS (Cont. Ops) | $1.97 | $3.16 | $3.26 | $2.56 | $2.39 | |
| Diluted EPS (Cont. Ops) | $1.97 | $3.16 | $3.26 | $2.55 | $2.39 | |
| Weighted Average Basic Share | $16M | $16.8M | $18M | $20.9M | $20.8M | |
| Weighted Average Diluted Share | $16M | $16.8M | $18M | $20.9M | $20.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $72.5M | $90.6M | $102.3M | $175.7M | $205.4M | |
| Revenue (Reported) | $159.6M | $189.4M | $219.6M | $218.1M | $222M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $72.5M | $90.6M | $102.3M | $175.7M | $205.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $46.7M | $51.2M | $54.2M | $53M | $55.8M | |
| Revenue Growth (YoY) | 35.06% | 9.77% | 5.76% | -2.2% | 5.25% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $15.5M | $18.3M | $18.5M | $20.5M | $22.1M | |
| Other Inc / (Exp) | $120K | $257K | -$264K | $191K | -$249K | |
| Operating Expenses | $15.5M | $18.3M | $18.5M | $20.5M | $20.5M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $17.4M | $18.7M | $20.4M | $15.4M | $14.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.3M | $3.5M | $3.9M | $2.8M | $2.9M | |
| Net Income to Company | $14.2M | $15.2M | $16.5M | $12.6M | $11.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14.2M | $15.2M | $16.5M | $12.6M | $11.5M | |
| Basic EPS (Cont. Ops) | $0.78 | $0.84 | $0.73 | $0.55 | $0.50 | |
| Diluted EPS (Cont. Ops) | $0.78 | $0.84 | $0.73 | $0.55 | $0.50 | |
| Weighted Average Basic Share | $16.8M | $16.8M | $21M | $20.8M | $20.9M | |
| Weighted Average Diluted Share | $16.8M | $16.8M | $21.1M | $20.9M | $20.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $22.6M | $22.4M | $39.4M | $48.1M | $48.3M | |
| Revenue (Reported) | $46.7M | $51.2M | $54.2M | $53M | $55.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $22.6M | $22.4M | $39.4M | $48.1M | $48.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $171.8M | $193.9M | $222.6M | $216.9M | $224.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $56.2M | $68.6M | $77.3M | $80.1M | $82.4M | |
| Other Inc / (Exp) | $3.2M | $1.7M | -$1M | $120K | $388K | |
| Operating Expenses | $43.7M | $68.6M | $77.3M | $80.1M | $80.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $47M | $72.1M | $79.9M | $66.9M | $66.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8.9M | $13.3M | $15.4M | $12.7M | $12.8M | |
| Net Income to Company | $38.1M | $58.8M | $64.4M | $54.1M | $53.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $38.1M | $58.8M | $64.4M | $54.1M | $53.5M | |
| Basic EPS (Cont. Ops) | $2.19 | $3.22 | $3.18 | $2.38 | $2.35 | |
| Diluted EPS (Cont. Ops) | $2.19 | $3.22 | $3.18 | $2.38 | $2.33 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $74.5M | $90.4M | $119.3M | $184.4M | $205.5M | |
| Revenue (Reported) | $171.8M | $193.9M | $222.6M | $216.9M | $224.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $74.5M | $90.4M | $119.3M | $184.4M | $205.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $46.7M | $51.2M | $54.2M | $53M | $55.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $15.5M | $18.3M | $18.5M | $20.5M | $22.1M | |
| Other Inc / (Exp) | $120K | $257K | -$264K | $191K | -$249K | |
| Operating Expenses | $15.5M | $18.3M | $18.5M | $20.5M | $20.5M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $17.4M | $18.7M | $20.4M | $15.4M | $14.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.3M | $3.5M | $3.9M | $2.8M | $2.9M | |
| Net Income to Company | $14.2M | $15.2M | $16.5M | $12.6M | $11.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14.2M | $15.2M | $16.5M | $12.6M | $11.5M | |
| Basic EPS (Cont. Ops) | $0.78 | $0.84 | $0.73 | $0.55 | $0.50 | |
| Diluted EPS (Cont. Ops) | $0.78 | $0.84 | $0.73 | $0.55 | $0.50 | |
| Weighted Average Basic Share | $16.8M | $16.8M | $21M | $20.8M | $20.9M | |
| Weighted Average Diluted Share | $16.8M | $16.8M | $21.1M | $20.9M | $20.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $22.6M | $22.4M | $39.4M | $48.1M | $48.3M | |
| Revenue (Reported) | $46.7M | $51.2M | $54.2M | $53M | $55.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $22.6M | $22.4M | $39.4M | $48.1M | $48.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $532.7M | $732.2M | $106.3M | $222M | $443M | |
| Short Term Investments | $584.9M | $697.2M | $371.4M | $342M | $403.5M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.1B | $1.4B | $477.7M | $564M | $846.5M | |
| Property Plant And Equipment | $78.5M | $81.6M | $100.8M | $109.4M | $128.7M | |
| Long-Term Investments | $591.6M | $707.6M | $785.8M | $740.2M | $785.1M | |
| Goodwill | $43.7M | $43.7M | $43.7M | $43.9M | $43.9M | |
| Other Intangibles | $2.1M | $2.1M | $2.2M | $1.8M | $1.5M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.7B | $5.3B | $5.5B | $5.8B | $6.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $132.4M | -- | -- | |
| Long-Term Debt | $70.6M | $104.3M | $104.6M | $104.9M | $105.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.3B | $4.9B | $4.9B | $5.2B | $5.6B | |
| Common Stock | $57.8M | $57.8M | $57.8M | $57.8M | $57.8M | |
| Other Common Equity Adj | -- | -$394K | -$52.5M | -$46.1M | -$43.6M | |
| Common Equity | $358.4M | $385.1M | $473M | $513.5M | $552.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $416.1M | $442.8M | $530.8M | $571.2M | $610.7M | |
| Total Liabilities and Equity | $4.7B | $5.3B | $5.5B | $5.8B | $6.2B | |
| Cash and Short Terms | $1.1B | $1.4B | $477.7M | $564M | $846.5M | |
| Total Debt | $70.6M | $104.3M | $104.6M | $104.9M | $105.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $653.2M | $405M | $188.6M | $301.5M | $520.2M | |
| Short Term Investments | $613.5M | $539.6M | $368.6M | $348.6M | $446.6M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.3B | $944.5M | $557.2M | $650M | $966.7M | |
| Property Plant And Equipment | $78.3M | $87.9M | $105.2M | $110.5M | $128.5M | |
| Long-Term Investments | $620.3M | $857.3M | $780.3M | $739.9M | $808.9M | |
| Goodwill | $43.7M | $43.7M | $43.9M | $43.9M | $43.9M | |
| Other Intangibles | $2.3M | $2.3M | $2.1M | $1.8M | $1.3M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.9B | $5.3B | $5.6B | $5.8B | $6.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $102.1M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $102.1M | -- | -- | |
| Long-Term Debt | $70.6M | $104.4M | $104.7M | $105M | $105.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.5B | $4.9B | $5B | $5.2B | $5.7B | |
| Common Stock | $57.8M | $57.8M | $57.8M | $57.8M | $57.8M | |
| Other Common Equity Adj | $5.9M | -$27.3M | -$46.7M | -$47.2M | -$36.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $417.6M | $425.9M | $546.4M | $578.6M | $624.5M | |
| Total Liabilities and Equity | $4.9B | $5.3B | $5.6B | $5.8B | $6.3B | |
| Cash and Short Terms | $1.3B | $944.5M | $557.2M | $650M | $966.7M | |
| Total Debt | $70.6M | $104.4M | $206.7M | $105M | $105.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $32.7M | $57.7M | $63.2M | $58M | $54.6M | |
| Depreciation & Amoritzation | $6.1M | $6.2M | $6.6M | $7.7M | $8.3M | |
| Stock-Based Compensation | $1.4M | $1.5M | $1.3M | $1.7M | $2.2M | |
| Change in Accounts Receivable | -$6.2M | -$1.1M | -$19.1M | -$5.9M | $389K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $28.8M | $58.9M | $64.1M | $47M | $71.5M | |
| Capital Expenditures | $5.6M | $6.5M | $12.3M | $11M | $16.3M | |
| Cash Acquisitions | $72.9M | -- | -- | -- | -- | |
| Cash From Investing | -$168.7M | -$409.8M | -$804.7M | -$149.5M | -$203.3M | |
| Dividends Paid (Ex Special Dividend) | -$12.1M | -$15.9M | -$16.9M | -$19M | -$19.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $232M | $83.5M | -- | -- | -- | |
| Long-Term Debt Repaid | -$459.9M | -$50M | -- | -- | -- | |
| Repurchase of Common Stock | -$1.3M | -$1.2M | -$1.7M | -$6.7M | -$643K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $479.6M | $550.3M | $114.7M | $218.2M | $352.8M | |
| Beginning Cash (CF) | $193M | $532.7M | $732.2M | $106.3M | $222M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $339.7M | $199.5M | -$625.9M | $115.8M | $221M | |
| Ending Cash (CF) | $532.7M | $732.2M | $106.3M | $222M | $443M | |
| Levered Free Cash Flow | $23.1M | $52.4M | $51.8M | $36.1M | $55.2M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14M | $15.4M | $13.8M | $13M | -- | |
| Depreciation & Amoritzation | $1.7M | $1.7M | $1.9M | $2M | -- | |
| Stock-Based Compensation | $303K | $256K | $345K | $482K | -- | |
| Change in Accounts Receivable | $598K | -$10.7M | -$2.8M | -$9.7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.8M | $18M | $11.6M | $10.4M | -- | |
| Capital Expenditures | $1M | $2.1M | $3.8M | $6.3M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$151.6M | -$145.8M | -$144.8M | -$48.8M | -- | |
| Dividends Paid (Ex Special Dividend) | -$3.9M | -$4M | -$4.7M | -$4.8M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $83.5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$1K | -$1K | -$2.3M | -$442K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $226.2M | $6.9M | $69.8M | $68.1M | -- | |
| Beginning Cash (CF) | $653.2M | $405M | $188.6M | $301.5M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $84.4M | -$120.8M | -$63.4M | $29.7M | -- | |
| Ending Cash (CF) | $737.7M | $284.2M | $125.2M | $331.1M | -- | |
| Levered Free Cash Flow | $8.8M | $15.9M | $7.8M | $4.1M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $38.1M | $58.8M | $64.4M | $54.1M | $53.5M | |
| Depreciation & Amoritzation | $6.5M | $6.3M | $6.7M | $7.7M | $8.4M | |
| Stock-Based Compensation | $1.4M | $1.5M | $1.4M | $2M | $1.8M | |
| Change in Accounts Receivable | -$4.4M | -$2M | -$15.7M | -$9.6M | $3.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $33.3M | $51.6M | $65.1M | $54.7M | $70.7M | |
| Capital Expenditures | $5.8M | $6.9M | $13.9M | $9.9M | $15.6M | |
| Cash Acquisitions | $72.9M | -- | -- | -- | -- | |
| Cash From Investing | -$172.2M | -$647.5M | -$520.8M | -$99.7M | -$254.4M | |
| Dividends Paid (Ex Special Dividend) | -$13.4M | -$16M | -$17.6M | -$19M | -$19.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$1.1M | -$2.7M | -$2.5M | -$4.4M | -$765K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $655.8M | $347.6M | $239.3M | $157.9M | $402.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $516.9M | -$248.3M | -$216.4M | $112.9M | $218.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $27.6M | $44.7M | $51.2M | $44.8M | $55.1M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $28.2M | $30.7M | $30.3M | $25.6M | $11.5M | |
| Depreciation & Amoritzation | $3.4M | $3.5M | $3.8M | $3.9M | $2.1M | |
| Stock-Based Compensation | $812K | $757K | $961K | $1.4M | $455K | |
| Change in Accounts Receivable | -$1.6M | -$13.8M | -$2.5M | -$13.2M | -$667K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $20.9M | $21.8M | $16.4M | $22.9M | $11.6M | |
| Capital Expenditures | $2.5M | $4M | $7.3M | $8.7M | $1.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$214.5M | -$446.3M | -$161.4M | -$15.7M | -$18M | |
| Dividends Paid (Ex Special Dividend) | -$7.9M | -$8.1M | -$9.5M | -$9.5M | -$4.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $83.5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$160K | -$1.7M | -$4.8M | -$652K | -$332K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $398.5M | -$23.5M | $163.9M | $101.9M | $83.5M | |
| Beginning Cash (CF) | $1.2B | $1.1B | $294.9M | $523.5M | $443M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $205M | -$448M | $18.9M | $109.1M | $77.1M | |
| Ending Cash (CF) | $1.4B | $689.1M | $313.8M | $632.6M | $520.2M | |
| Levered Free Cash Flow | $18.5M | $17.8M | $9.1M | $14.2M | $9.9M | |
Get CCNE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CCNE
Sector
P/E ratio
10.40x
12.21x
PEG ratio
--
0.40x
P/B ratio
0.90x
1.11x
Price / LTM sales
2.25x
2.66x
Growth Metrics
CCNE
Sector
Revenue growth
5.25%
5.12%
Earnings growth
-9.09%
2.63%
Revenue (5-year growth)
9.77%
5.17%
Earnings forecast
$0.59
$0.61
Profitability
CCNE
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
7.57%
5.21%
Return on assets
0.89%
0.97%
Return on equity
8.89%
9.24%
Earnings Date
Last Earnings Date
Apr
14
Next Earnings Date
Jul
18
Estimated Next Earnings Date
Jul
14
Balance Sheet
CCNE
Sector
Total cash
$966.7M
$451.2M
Short term investments
$403.5M
$220.9M
Total assets
$6.2B
$3.8B
Long term debt
$105.3M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
